BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 12884887)

  • 1. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone.
    Kosten T; Falcioni J; Oliveto A; Feingold A
    Am J Addict; 2004; 13(2):191-201. PubMed ID: 15204669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
    Feingold A; Oliveto A; Schottenfeld R; Kosten TR
    Am J Addict; 2002; 11(2):111-23. PubMed ID: 12028741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
    Kosten T; Oliveto A; Feingold A; Poling J; Sevarino K; McCance-Katz E; Stine S; Gonzalez G; Gonsai K
    Drug Alcohol Depend; 2003 Jun; 70(3):315-25. PubMed ID: 12757969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
    Sofuoglu M; Gonzalez G; Poling J; Kosten TR
    Am J Drug Alcohol Abuse; 2003; 29(4):713-27. PubMed ID: 14713135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
    Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
    Oliveto A; Kosten TR; Schottenfeld R; Falcioni J; Ziedonis D
    J Subst Abuse Treat; 1995; 12(6):423-8. PubMed ID: 8749726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response.
    Kosten T; Sofuoglu M; Poling J; Gonsai K; Oliveto A
    Am J Addict; 2005; 14(1):8-17. PubMed ID: 15804873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.
    Kosten TR; Morgan CM; Falcione J; Schottenfeld RS
    Arch Gen Psychiatry; 1992 Nov; 49(11):894-8. PubMed ID: 1444728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients.
    Kosten T; Poling J; Oliveto A
    Addiction; 2003 May; 98(5):665-71. PubMed ID: 12751984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
    Ling W; Wesson DR; Charuvastra C; Klett CJ
    Arch Gen Psychiatry; 1996 May; 53(5):401-7. PubMed ID: 8624183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in Buprenorphine- versus methadone-maintained patients.
    Schottenfeld RS; Pakes JR; Kosten TR
    J Nerv Ment Dis; 1998 Jan; 186(1):35-43. PubMed ID: 9457145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desipramine treatment of cocaine dependence in methadone-maintained patients.
    Arndt IO; Dorozynsky L; Woody GE; McLellan AT; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):888-93. PubMed ID: 1444727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine versus methadone maintenance for opioid dependence.
    Kosten TR; Schottenfeld R; Ziedonis D; Falcioni J
    J Nerv Ment Dis; 1993 Jun; 181(6):358-64. PubMed ID: 8501457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients.
    Mattick RP; Ali R; White JM; O'Brien S; Wolk S; Danz C
    Addiction; 2003 Apr; 98(4):441-52. PubMed ID: 12653814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind randomized trial of buprenorphine and methadone in opiate dependence.
    Petitjean S; Stohler R; Déglon JJ; Livoti S; Waldvogel D; Uehlinger C; Ladewig D
    Drug Alcohol Depend; 2001 Mar; 62(1):97-104. PubMed ID: 11173173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.